-
Forbion Portfolio Company, AM-Pharma raises €116m
July 16, 2019Forbion Portfolio Company, AM-Pharma raises €116m to conduct Pivotal Phase III Trial of recAP in acute kidney injury. Please...
0 -
Forbion announces that Pfizer acquires interest in its portfolio Company AM-Pharma
May 12, 2015Pfizer acquires minority interest in AM-Pharma; Secures option to acquire company. Option may be exercised based on Phase II...
